Cargando…
Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’
Autores principales: | Dauby, N., Catteau, L., Hautekiet, J., Montourcy, M., Bottieau, E., Goetghebeur, E., Van Beckhoven, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733680/ https://www.ncbi.nlm.nih.gov/pubmed/33321211 http://dx.doi.org/10.1016/j.ijantimicag.2020.106261 |
Ejemplares similares
-
Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of ‘goals of care’”
por: Dauby, Nicolas, et al.
Publicado: (2021) -
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
por: Catteau, Lucy, et al.
Publicado: (2020) -
Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
por: De Schryver, Nicolas, et al.
Publicado: (2021) -
The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021) -
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply
por: Rentsch, Christopher T, et al.
Publicado: (2021)